FDA Approves Boostrix for Third-Trimester Administration

WEDNESDAY, Oct. 12, 2022 -- The U.S. Food and Drug Administration has approved Boostrix for immunization during the third trimester of pregnancy to prevent pertussis in infants younger than 2 months of age.
The Boostrix vaccine (Tetanus Toxoid,...